Charles Schwab’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-60,500
| Closed | -$224K | – | 3083 |
|
|
2017
Q4 | $224K | Hold |
60,500
| – | – | ﹤0.01% | 2960 |
|
|
2017
Q3 | $248K | Hold |
60,500
| – | – | ﹤0.01% | 2943 |
|
|
2017
Q2 | $225K | Buy |
+60,500
| New | +$225K | ﹤0.01% | 2990 |
|
|
2016
Q4 | – | Sell |
-4,283
| Closed | -$43K | – | 3078 |
|
|
2016
Q3 | $43K | Hold |
4,283
| – | – | ﹤0.01% | 3026 |
|
|
2016
Q2 | $25K | Sell |
4,283
-25,285
| -86% | -$148K | ﹤0.01% | 3090 |
|
|
2016
Q1 | $226K | Hold |
29,568
| – | – | ﹤0.01% | 2861 |
|
|
2015
Q4 | $394K | Hold |
29,568
| – | – | ﹤0.01% | 2749 |
|
|
2015
Q3 | $487K | Hold |
29,568
| – | – | ﹤0.01% | 2634 |
|
|
2015
Q2 | $664K | Buy |
29,568
+7,985
| +37% | +$179K | ﹤0.01% | 2569 |
|
|
2015
Q1 | $212K | Hold |
21,583
| – | – | ﹤0.01% | 2935 |
|
|
2014
Q4 | $247K | Hold |
21,583
| – | – | ﹤0.01% | 2919 |
|
|
2014
Q3 | $249K | Hold |
21,583
| – | – | ﹤0.01% | 2874 |
|
|
2014
Q2 | $420K | Buy |
21,583
+17,300
| +404% | +$337K | ﹤0.01% | 2705 |
|
|
2014
Q1 | $77K | Hold |
4,283
| – | – | ﹤0.01% | 3048 |
|
|
2013
Q4 | $46K | Hold |
4,283
| – | – | ﹤0.01% | 3071 |
|
|
2013
Q3 | $53K | Hold |
4,283
| – | – | ﹤0.01% | 3049 |
|
|
2013
Q2 | $42K | Buy |
+4,283
| New | +$42K | ﹤0.01% | 3035 |
|